Ra Capital Management as of March 31, 2017
Portfolio Holdings for Ra Capital Management
Ra Capital Management holds 24 positions in its portfolio as reported in the March 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Wave Life Sciences (WVE) | 23.9 | $195M | 7.1M | 27.50 | |
| Ascendis Pharma A S (ASND) | 18.6 | $152M | 5.4M | 28.00 | |
| Avexis | 15.2 | $124M | 1.6M | 76.03 | |
| Achillion Pharmaceuticals | 7.0 | $57M | 14M | 4.21 | |
| Aquinox Pharmaceuticals | 4.4 | $36M | 2.2M | 16.57 | |
| BioCryst Pharmaceuticals (BCRX) | 3.6 | $29M | 3.5M | 8.40 | |
| Ra Pharmaceuticals | 3.5 | $29M | 1.4M | 21.29 | |
| Myovant Sciences | 3.4 | $28M | 2.3M | 11.74 | |
| Zogenix | 3.3 | $27M | 2.5M | 10.85 | |
| Esperion Therapeutics (ESPR) | 3.0 | $25M | 705k | 35.31 | |
| Loxo Oncology | 1.5 | $13M | 299k | 42.08 | |
| Ardelyx (ARDX) | 1.3 | $11M | 828k | 12.65 | |
| Acorda Therapeutics | 1.3 | $10M | 490k | 21.00 | |
| Foamix Pharmaceuticals | 1.1 | $9.0M | 1.8M | 4.95 | |
| Audentes Therapeutics | 1.1 | $9.1M | 532k | 17.04 | |
| Ignyta | 1.1 | $8.8M | 1.0M | 8.60 | |
| Beigene (BGNE) | 1.1 | $8.8M | 240k | 36.61 | |
| Calithera Biosciences | 1.0 | $8.4M | 725k | 11.55 | |
| Dicerna Pharmaceuticals | 1.0 | $8.3M | 2.4M | 3.40 | |
| Tg Therapeutics (TGTX) | 1.0 | $8.2M | 700k | 11.65 | |
| Protagonist Therapeutics (PTGX) | 1.0 | $8.2M | 636k | 12.81 | |
| Kalvista Pharmaceuticals (KALV) | 0.6 | $4.6M | 591k | 7.81 | |
| Eiger Biopharmaceuticals | 0.5 | $4.1M | 354k | 11.45 | |
| Medicines Company | 0.5 | $3.9M | 80k | 48.90 |
